14 Results for "

VGF

" in MedChemExpress (MCE) Product Catalog:
Products (14)

14 Results for "VGF" in MCE Product Catalog:

2
2 Cited Publications
Cat. No.: HY-P1345A
Target:  

Complement System

Research Areas:  

Neurological Disease Endocrinology

TLQP-21 TFA, a VGF-derived peptide endowed of endocrine and extraendocrine properties, is a potent G-protein-coupled receptor complement-3a receptor1 (C3aR1) agonist (EC50: mouse TLQP-21=10.3 μM; human TLQP-21=68.8μM). TLQP-21 TFA activates C3aR1 to induce an increase of intracellular Ca 2+. TLQP-21 TFA is used for the research in regulation of nociception and other relevant physiologic functions .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-107760
CAS No.: 150113-99-8
Purity:  98.02%
Synonyms: DecRVKRcmk
Target:  

HIV

Research Areas:  

Infection Inflammation/Immunology

Decanoyl-RVKR-CMK (DecRVKRcmk) inhibits over-expressed gp160 processing and HIV-1 replication .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-16728
CAS No.: 117928-94-6
Synonyms: GLYX-13
Target:  

iGluR ERK mTOR

Research Areas:  

Neurological Disease Cancer

Rapastinel (GLYX-13) is a potent NMDAR modulator capable of crossing the blood-brain barrier, and it exhibits extremely high affinity for human NMDAR (EC50=0.0017-9.9 nM). Rapastinel enhances ERK signaling and activates the mTOR pathway, thereby upregulating the expression of BDNF and VGF, and inducing significant neuroplastic changes such as enhanced LTP and increased mature dendritic spine density in the hippocampus. Rapastinel moderately elevates the efflux of dopamine, norepinephrine and 5-HT in the prefrontal cortex, and uniquely avoids side effects of traditional antidepressants such as dissociation, addiction or sedation. Rapastinel is applicable to the research of major depressive disorder and hepatocellular carcinoma .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-107760A
CAS No.: 2098497-25-5
Purity:  96.40%
Synonyms: DecRVKRcmk TFA
Target:  

HIV

Research Areas:  

Infection Inflammation/Immunology

Decanoyl-RVKR-CMK (DecRVKRcmk) TFA inhibits over-expressed gp160 processing and HIV-1 replication .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-16728B
CAS No.: 1435786-04-1
Synonyms: GLYX-13 Trifluoroacetate
Target:  

iGluR mTOR ERK

Research Areas:  

Neurological Disease

Rapastinel (GLYX-13) Trifluoroacetate is a potent NMDAR modulator capable of crossing the blood-brain barrier, and it exhibits extremely high affinity for human NMDAR (EC50=0.0017-9.9 nM). Rapastinel Trifluoroacetate enhances ERK signaling and activates the mTOR pathway, thereby upregulating the expression of BDNF and VGF, and inducing significant neuroplastic changes such as enhanced LTP and increased mature dendritic spine density in the hippocampus. Rapastinel Trifluoroacetate moderately elevates the efflux of dopamine, norepinephrine and 5-HT in the prefrontal cortex, and uniquely avoids side effects of traditional antidepressants such as dissociation, addiction or sedation. Rapastinel Trifluoroacetate is applicable to the research of major depressive disorder and hepatocellular carcinoma .
loading...
    loading...
Cat. No.: HY-P1345
CAS No.: 869988-94-3
Target:  

Complement System

Research Areas:  

Neurological Disease Endocrinology

TLQP-21, a VGF-derived peptide endowed of endocrine and extraendocrine properties, is a potent G-protein-coupled receptor complement-3a receptor 1 (C3aR1) agonist (EC50: mouse TLQP-21=10.3 μM; human TLQP-21=68.8 μM). TLQP-21 activates C3aR1 to induce an increase of intracellular Ca 2+. TLQP-21 is used for the research in regulation of nociception and other relevant physiologic functions .
loading...
    loading...
Cat. No.: HY-RS17940
Research Areas:  

Others

Vgf Mouse Pre-designed siRNA Set A contains three designed siRNAs for Vgf gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-P11130
CAS No.: 322644-72-4
Target:  

Akt ERK PI3K MEK

Research Areas:  

Neurological Disease

LQEQ-19 (mouse, rat) is a VGF derived peptide that exerts neuroprotective effects. LQEQ-19 (mouse, rat) activates the PI3K/Akt and MEK/ERK signaling pathways by promoting phosphorylation of Akt and ERK1/2. LQEQ-19 (mouse, rat) is commonly used in the study of neurological conditions .
loading...
    loading...
Cat. No.: HY-RS15643
Research Areas:  

Others

VGF Human Pre-designed siRNA Set A contains three designed siRNAs for VGF gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-RS24411
Research Areas:  

Others

Vgf Rat Pre-designed siRNA Set A contains three designed siRNAs for Vgf gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-P11092
Target:  

Endogenous Metabolite

Research Areas:  

Neurological Disease

TLQP-62 (mouse,rat) is a secreted C-terminal peptide that can be derived from protein VGF. TLQP-62 activates the BDNF-TrkB signaling pathway, inducing acute, transient phosphorylation of TrkB receptor and downstream CREB (Ser133) phosphorylation. TLQP-62 demonstrates excellent efficacy in promoting long-term fear memory formationin wild-type mice and reversing memory impairment in VGF heterozygous knock-out mice. TLQP-62 can be used for the study of memory-related neurological disorders (e.g., Alzheimer’s disease, frontotemporal dementia) .
loading...
    loading...
Cat. No.: HY-P11192
Target:  

Peptides

Research Areas:  

Metabolic Disease

AQEE-30 (mouse, rat) is a VGF-derived neuropeptide. AQEE-30 (mouse, rat) can be upregulated upon high caloric feeding in rats. AQEE-30 (mouse, rat) can be used in obesity research .
loading...
    loading...
Cat. No.: HY-16728A
CAS No.: 491872-39-0
Synonyms: GLYX-13 acetate
Target:  

iGluR mTOR ERK

Research Areas:  

Neurological Disease

Rapastinel (GLYX-13) acetate is a potent NMDAR modulator capable of crossing the blood-brain barrier, and it exhibits extremely high affinity for human NMDAR (EC50=0.0017-9.9 nM). Rapastinel acetate enhances ERK signaling and activates the mTOR pathway, thereby upregulating the expression of BDNF and VGF, and inducing significant neuroplastic changes such as enhanced LTP and increased mature dendritic spine density in the hippocampus. Rapastinel acetate moderately elevates the efflux of dopamine, norepinephrine and 5-HT in the prefrontal cortex, and uniquely avoids side effects of traditional antidepressants such as dissociation, addiction or sedation. Rapastinel acetate is applicable to the research of major depressive disorder and hepatocellular carcinoma .
loading...
    loading...
Cat. No.: HY-P1814
CAS No.: 922704-13-0
Target:  

Peptides

Research Areas:  

Metabolic Disease

TLQP-30 is a VGF peptide .
loading...
    loading...
  • 1